This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Amgen Fremont Inc., Celldex Therapeutics Limited, Curagen Corporation. Active years: 2011-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 78 
1 out of 45 
1 out of 84 
Years Active: 2011-2017
Title: Innovations of Nikolia Khramtsov
Introduction
Nikolia Khramtsov is a notable inventor based in Branford, CT (US). He has made significant contributions to the field of immunology, particularly through his work on antibodies.
Latest Patents
Khramtsov holds 2 patents, with his latest inventions focusing on antibodies against the T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen. The inventions describe fully human monoclonal antibodies directed to the TIM-1 antigen. They include isolated polynucleotide sequences encoding heavy and light chain immunoglobulin molecules, as well as hybridomas or other cell lines expressing these immunoglobulin molecules and monoclonal antibodies.
Career Highlights
Throughout his career, Nikolia Khramtsov has worked with several prominent companies, including Curagen Corporation and Celldex Therapeutics Limited. His work has significantly advanced the understanding and application of immunological therapies.
Collaborations
Khramtsov has collaborated with notable colleagues such as Gregory M Landes and Francine Zhifen Chen. These collaborations have contributed to the development of innovative solutions in the field of immunology.
Conclusion
Nikolia Khramtsov's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of therapeutic antibodies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile